Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment

This study has been completed.
Information provided by:
Zeria Pharmaceutical Identifier:
First received: February 6, 2006
Last updated: May 29, 2009
Last verified: May 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)